Literature DB >> 27743246

Dopamine-Secreting Paraganglioma in the Retroperitoneum.

Yusuke Matsuda1,2, Noriko Kimura3, Takanobu Yoshimoto4, Yoshihiro Sekiguchi1, Junzo Tomoishi5, Ichiro Kasahara6, Yoshihito Hara1, Yoshihiro Ogawa2.   

Abstract

Pheochromocytomas and paragangliomas, which exclusively produce dopamine, are very rare. Herein, we report for the first time a Japanese case of an exclusively dopamine-producing paraganglioma accompanied by detailed immunohistochemical analyses. A 70-year-old Japanese woman was referred to our hospital for functional examination of her left retroperitoneal mass. Her adrenal functions were normal, except for excessive dopamine secretion. After the tumorectomy, her dopamine level normalized. The histopathological diagnosis of the tumor was paraganglioma; this was confirmed by positive immunostaining of chromogranin A (CgA), tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH), and succinate dehydrogenase gene subunit B (SDHB). However, the immunostaining of CgA in the tumor cells showed peculiar dot-like staining located corresponding to Golgi complex in the perinuclear area, rather than the diffuse cytoplasmic staining usually observed in epinephrine- or norepinephrine-producing functional pheochromocytomas and paragangliomas. The immunohistochemical results suggested that the tumor cells had sparse neuroendocrine granules in the cytoplasm, resulting in inhibition of catecholamine synthesis from dopamine to norepinephrine in neurosecretory granules. This may be the mechanism responsible for exclusive dopamine secretion in the present case.

Entities:  

Keywords:  Chromogranin a; Dopamine; Immunohistochemistry; Paraganglioma; Pheochromocytoma

Mesh:

Substances:

Year:  2017        PMID: 27743246     DOI: 10.1007/s12022-016-9457-0

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  14 in total

Review 1.  Management of exclusively dopamine-secreting abdominal pheochromocytomas.

Authors:  Éric Poirier; Daniel Thauvette; Jean-Charles Hogue
Journal:  J Am Coll Surg       Date:  2012-11-30       Impact factor: 6.113

Review 2.  Chromogranin A: a surprising link between granule biogenesis and hypertension.

Authors:  Taeyoon Kim; Y Peng Loh
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

3.  Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas.

Authors:  J M Feldman; J A Blalock; R T Zern; J D Shelburne; J T Gaede; R E Farrell; S A Wells
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

4.  The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma.

Authors:  Vicki Tam; K F Ng; L M Fung; Y Y Wong; Michael H M Chan; C W Lam; Sidney Tam; Christopher W K Lam
Journal:  Ann Clin Biochem       Date:  2005-01       Impact factor: 2.057

5.  Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.

Authors:  Graeme Eisenhofer; David S Goldstein; Patricia Sullivan; Gyorgy Csako; Frederieke M Brouwers; Edwin W Lai; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

6.  Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.

Authors:  Noriko Kimura; Ryoichi Takayanagi; Nae Takizawa; Eiji Itagaki; Takayuki Katabami; Narihiko Kakoi; Hiromi Rakugi; Yukihiro Ikeda; Akiyo Tanabe; Takeshi Nigawara; Sadayoshi Ito; Itaru Kimura; Mitsuhide Naruse
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

7.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.

Authors:  C Proye; P Fossati; P Fontaine; J Lefebvre; M Decoulx; J L Wemeau; D Dewailly; E Rwamasirabo; P Cecat
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

8.  Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy.

Authors:  T van Gelder; G T Verhoeven; P de Jong; H Y Oei; E P Krenning; V D Vuzevski; A H van den Meiracker
Journal:  J Nucl Med       Date:  1995-04       Impact factor: 10.057

9.  The value of plasma markers for the clinical behaviour of phaeochromocytomas.

Authors:  E van der Harst; W W de Herder; R R de Krijger; H A Bruining; H J Bonjer; S W J Lamberts; A H van den Meiracker; T H Stijnen; F Boomsma
Journal:  Eur J Endocrinol       Date:  2002-07       Impact factor: 6.664

10.  An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea.

Authors:  Jin Wook Yi; Eun Mee Oh; Kyu Eun Lee; June Young Choi; Do Hoon Koo; Kyung Joo Kim; Kyeong-Cheon Jung; Seong-Yeon Kim; Yeo-Kyu Youn
Journal:  J Korean Surg Soc       Date:  2012-05-29
View more
  2 in total

Review 1.  Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.

Authors:  Ozgur Mete; Sylvia L Asa; Anthony J Gill; Noriko Kimura; Ronald R de Krijger; Arthur Tischler
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

Review 2.  Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine.

Authors:  Noriko Kimura; Kazuhiro Takekoshi; Mitsuhide Naruse
Journal:  J Clin Med       Date:  2018-08-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.